Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers

BACKGROUND: The efficacy and safety of using combination chemotherapy with cetuximab as first-line treatment in patients with K-ras wild-type colorectal cancers has been well established. In general, weekly cetuximab was given with biweekly chemotherapy FOLFOX-4 or FOLFIRI, synchronizing them would...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Wing-Lok, Lee, Victor Ho Fun, Siu, Wai Kwan Steven, Ho, Pui Ying Patty, Liu, Rico King Yin, Leung, To Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
COLORECTAL CANCER: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134610/
https://www.ncbi.nlm.nih.gov/pubmed/25136526
http://dx.doi.org/10.4103/2278-330X.136802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134610/
https://www.ncbi.nlm.nih.gov/pubmed/25136526
http://dx.doi.org/10.4103/2278-330X.136802

Ejemplares similares